Biocartis Investors
Biocartis is a molecular diagnostics company that focuses on developing innovative testing solutions for precision medicine. Their flagship product, the Idylla platform, enables rapid and accurate testing for various cancers and infectious diseases. The company aims to improve patient outcomes by providing healthcare professionals with timely and actionable insights. Biocartis is committed to making advanced diagnostics accessible and efficient for laboratories worldwide.
Investors
.png)
%20.jpg)
Connections
Investor Type:
Healthcare Company
Employee Number:
1-10
Industry:
Advanced Longevity (R&D)